Others have shown that the increase of seizure susceptibility in APP mouse model was dependent on the expression of tau [15,16], which suggests that intervening the interaction between amyloid and tau might have therapeutic potential for epilepsy management in AD patients. The gene discussed is MAPT; the disease is epilepsy.